Skip to content

Use of Homeopathy in Patients Suffering From Long COVID-19

Use of Homeopathy in Patients Suffering From Long COVID-19 (LONGCOVIHOM): A Retrospective Case Series

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06002230
Acronym
LONGCOVIHOM
Enrollment
15
Registered
2023-08-21
Start date
2021-01-05
Completion date
2023-08-10
Last updated
2023-08-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adjustment Reaction With Physical Symptoms

Keywords

Complementary therapy, Homeopathy, COVID-19, Long-COVID-19, SARS-CoV-2

Brief summary

In some patients, coronavirus (COVID-19) can cause symptoms that last weeks or even months after the infection has gone. The aim of this study was to describe the effect of adjunctive individualized homeopathic treatment delivered to Long-COVID-19 patients with previously confirmed symptomatic SARS-CoV-2 infection.

Detailed description

All patients had been tested positive for SARS-CoV-2 before having developed Long-COVID-19 symptoms. Several testing methods were carried out in each patient to analyze a SARS-CoV-2 infection. For a confirmed infection, at least 3 out of these 5 tests had to be positive. Tests for the orthomyxoviruses influenza A and B, human metapneumovirus (hMPV) and paramyxoviruses were negative unless stated otherwise. The homeopathic physician treated all Long-COVID-19 patients by individualized homeopathy. Repertorization of the symptoms of the current pandemic and a search in the current homeopathic literature on COVID-19 was performed using computer program. All available homeopathic medicinal products (HMPs) could be chosen by the treating physician. Modified MONARCH criteria were assessed post hoc by all authors. Deviations were solved by discussion in person. Clinical outcome of case reports was evaluated using the Modified Naranjo Criteria for Homeopathy-Causal Attribution Inventory. Eight points is assumed as the limit for potential correlation between homeopathic therapy and amelioration of the symptoms or healing in chronic cases.

Interventions

DRUGHomeopathic medicines

Globules were administered orally..

Sponsors

Sigmund Freud PrivatUniversitat
CollaboratorOTHER
Michael Frass
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 100 Years

Inclusion criteria

Long COVID-19 symptoms following recovery from SARS-CoV-2 infection

Exclusion criteria

Patients not signing informed consent

Design outcomes

Primary

MeasureTime frameDescription
Modified Naranjo criteria3 days10 Naranjo criteria are evaluated, eight points is assumed as the limit for potential correlation between homeopathic therapy and amelioration of the symptoms or healing in chronic cases.

Countries

Austria

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026